On Monday Eastern Time, the three major US stock indexes collectively closed lower, with the Dow Jones Industrial Average falling 0.11%, the Nasdaq falling 0.84%, and the S&P 500 Index falling 0.54%. Most popular technology stocks fell, with Intel falling more than 3%, Nvidia and AMD falling more than 2%, and Microsoft, Amazon, and Meta falling more than 1%. The precious metals, industrial raw materials, and lithium battery sectors saw the largest decline, with Chile's mining and chemical industry falling more than 8%, Gold Fields and the US Yabao falling more than 4%, Cordillera Mining, Southern Copper, Vale, and MAG Silver falling more than 3%, and Rio Tinto and BHP Billiton falling more than 2%. The cruise concept, infrastructure operation, and real estate trust sectors have risen, with Norwegian cruise ships up over 6%, Kate Property Trust and Carnival cruise ships up over 3%, and Jinke up over 2%.
Most popular Chinese concept stocks fell, with the Nasdaq China Golden Dragon Index falling 2.09%. NetEase and Manbang fell more than 4%, Futu Holdings fell more than 3%, Weibo, Baidu, Vipshop, and JD.com fell more than 2%, Pinduoduo, Tencent Music, Ideal Automobile, and Alibaba fell more than 1%. NIO rose by over 2%, Xiaopeng Motors and iQiyi rose by over 1%, and Bilibili slightly increased.
Global News

Keep playing music and dancing? After the "Crazy November" of the US stock market, there may be a "Crazy December"
In November this year, the US stock market achieved its second best performance since 1980. Some market insiders predict that the crazy rise of the US stock market will continue in December, supported by technical and seasonal factors.
2023 China Europe Financial and Investment Forum held to discuss high-quality development of capital markets
What are the key connotations of financial supply side structural reform as the main line of future financial work? How should high-quality development of the capital market be promoted? On December 3rd, at the 2023 China Europe Finance and Investment Forum and CLF50 Annual Conference, hosted by China Europe International Business School and China Europe Lujiazui International Financial Research Institute, academic and industry experts provided suggestions for the future development of the financial industry and the high-quality development of the capital market.
Gold is killing me crazy! 15% surge within the year, becoming an investment "instant bag". The world's largest gold ETF has significantly increased its holdings
Gold has gone crazy. On Monday of this week, gold hit a new historical high of $2120.04/ounce, with a cumulative increase of over 15% this year, making it one of the best investment products for 2023. The holdings of SPDR, the world's largest gold ETF, have reached 878.82 tons, an increase of 30 tons compared to October's low of 848.24 tons.
Still worried about inflation? In these commodity sectors, the "deflationary shadow" of the United States has emerged
The latest pricing of interest rate swap contracts shows that market traders have expected the probability of the Federal Reserve cutting interest rates in March next year to exceed 50%. At the same time, strong expectations of interest rate cuts are driving cross asset categories such as US stocks, US bonds, and gold to significantly increase.
Company News
Huang Renxun: NVIDIA will prioritize Japan's demand for AI chips as much as possible
On Monday (December 4th) local time, NVIDIA CEO Huang Renxun stated that although the market demand is extremely high, NVIDIA will still prioritize Japan's demand for artificial intelligence (AI) chips as much as possible.
Catalog number 214! NIO Auto has obtained independent production qualifications for nearly 3 billion yuan and has taken over F1 and F2 factories
On the day before the release of its 2023 third quarter report, NIO Automobile welcomed its unique "identity code" - "Road Motor Vehicle Production Enterprises and Products" catalog announcement, serial number 214.
Roche will also enter the weight loss drug market! Announced acquisition of Carmot for $2.7 billion
Swiss pharmaceutical giant Roche is joining the global weight loss drug market, seeking to challenge weight loss drug giants Novo Nordisk and Lilly. The company has recently agreed to acquire weight loss drug developer Carmot Therapeutics for $2.7 billion.